StartUp Health May 24, 2022

This week’s global health innovation funding included several startups focused on IVF and healthy pregnancies, as well as multiple others focused on learning differences and children’s wellbeing.

More than $235M in global health innovation funding was reported this week, led by Mirvie, a South San Francisco, CA-based startup focused on predicting pregnancy complications. The $60M Series B was led by Decheng Capital, with participation from BlackRock, Foresite Capital, General Catalyst, GV, Khosla Ventures, and Mayfield, as well as a debt facility with Comerica Bank. source>

Other recent deals included:

Noyo, a San Francisco, CA-based API platform focused on the employee benefits industry, raised $45M led by Norwest Venture Partners, with participation from Workday Ventures, Gusto, Cap Table Coalition,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Investments, Technology, Trends
Funding Flows to Value-Based Care, Defib Tech, Analytics, and More | StartUp Health Insights: Week of Apr 23, 2024
Evidence On Private Equity Suggests That Containing Costs And Improving Outcomes May Go Hand-In-Hand
Healthy Returns: Biotech IPOs ramped up to start 2024, but the market hasn't fully recovered just yet
‘Investors Are Hungry To Find the Best’: It’s Feast or Famine in Digital Behavioral Health Investing
Avive scores $57M for portable cardiac arrest device

Share This Article